EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases.
(Updated 12:12 and 12:37 p.m.)
General Electric Co. plans to open a new GE Digital information technology center, which will bring “hundreds” of new technology jobs to Providence, Gov. Gina M. Raimondo said Thursday.
(Updated 3:13 p.m.)
Nearly 60 percent of all visits to Rhode Island emergency rooms in 2014 were potentially preventable, according to a report issued Wednesday by R.I.’s Executive Office of Health and Human Services.